Go to home page - PHARMAC - Pharmaceutical Management Agency
Leading Edge Medicines Management home
Patients & Consumers Health Professionals District Health Boards Pharmaceutical Suppliers

Fri Jul 4 2008 NZST

RSSRSS feed (help)

Special Authority Forms

General Practitioners and specialists can download individual forms for making Special Authority applications from this page.

Alternatively, all forms are available in one indexed document, Special Authority Forms, July 2008 (154 pages, 434 KB).

Sort by Therapeutic Group or Form Title (Chemical Name)

Alimentary Tract and Metabolism

From page 24 of the Pharmaceutical Schedule, July 2008 (224 pages, 1342 KB)

Blood and Blood Forming Organs

From page 38 of the Pharmaceutical Schedule, July 2008 (224 pages, 1342 KB)

Cardiovascular System

From page 52 of the Pharmaceutical Schedule, July 2008 (224 pages, 1342 KB)

Dermatologicals

From page 61 of the Pharmaceutical Schedule, July 2008 (224 pages, 1342 KB)

Genito-Urinary System

From page 71 of the Pharmaceutical Schedule, July 2008 (224 pages, 1342 KB)

Hormone Preparations - Systemic Excluding Contraceptive Hormones

From page 77 of the Pharmaceutical Schedule, July 2008 (224 pages, 1342 KB)

Infections - Agents for Systemic Use

From page 88 of the Pharmaceutical Schedule, July 2008 (224 pages, 1342 KB)

Musculo-skeletal System

From page 100 of the Pharmaceutical Schedule, July 2008 (224 pages, 1342 KB)

Nervous System

From page 105 of the Pharmaceutical Schedule, July 2008 (224 pages, 1342 KB)

Oncology Agents and Immunosuppressants

From page 127 of the Pharmaceutical Schedule, July 2008 (224 pages, 1342 KB)

Respiratory System and Allergies

From page 146 of the Pharmaceutical Schedule, July 2008 (224 pages, 1342 KB)

Sensory Organs

From page 153 of the Pharmaceutical Schedule, July 2008 (224 pages, 1342 KB)

Various

From page 158 of the Pharmaceutical Schedule, July 2008 (224 pages, 1342 KB)

Extemporaneously Compounded Preparations and Galenicals

From page 163 of the Pharmaceutical Schedule, July 2008 (224 pages, 1342 KB)

Special Foods

From page 166 of the Pharmaceutical Schedule, July 2008 (224 pages, 1342 KB)

Data

Active Special Authority numbers for atorvastatin (Lipitor) (2 pages, 489 KB) – listing of active Special Authority approvals for atorvastatin (Lipitor) from 1 June 2004 (other than approvals under the new criteria).

Special Authority approvals for atorvastatin (Lipitor) (40 pages, 828 KB)) – from 1 June 2004 (other than approvals under the new criteria).

Page updated on 01 Jul 2008


Linked documents

page1

Special Authority Forms, July 2008 (154 pages, 434 KB)
SPECIAL AUTHORITY FORMS July 2008 Contents Panel Approvals… 4 Alimentary Tract and Metabolism … 5 Blood and Blood Forming Organs…. 14 Cardiovascular System ….. 27 Genito-Urinary System… 32 Hormone Preparations - Systemic Excluding Contraceptive Hormones… 34 Infections - Agents for…

text


page1

Pharmaceutical Schedule, July 2008 (224 pages, 1342 KB)
Introducing PHARMAC 2 July 2008 Volume 15 Number 1 Editors Linda Wellington & Kaye Wilson email: schedule@pharmac.govt.nz Telephone +64 4 460 4990 Facsimile +64 4 460 4995 Level 14, Cigna House 40 Mercer Street PO Box 10 254 Wellington Freephone…

text


page1

SA0855 – Multiple Sclerosis treatments, Initial Application for beta-interferon or glatiramer acetate (8 pages, 183 KB)
INITIAL APPLICATION FOR FUNDING OF BETA-INTERFERON OR GLATIRAMER ACETATE Please send applications to: The Co-ordinator MSTAC PHARMAC P O Box 10-254 WELLINGTON Phone: 04 460 4990 Facsimile: 04 916 7571 Email: mstaccoordinator@pharmac.govt.nz Applications must be complete and accompanied by all…

text


page1

SA0855 – Multiple Sclerosis treatments, Renewal Application form for beta-interferon or glatiramer acetate (5 pages, 171 KB)
RENEWAL APPLICATION FOR FUNDING OF BETA-INTERFERON OR GLATIRAMER ACETATE For patients who are currently being treated with beta-interferon or glatiramer acetate (with New Zealand government funding) Please send applications to: The Co-ordinator MSTAC PHARMAC P O Box 10-254 WELLINGTON Phone:…

text


page1

Active Special Authority numbers for atorvastatin (Lipitor) (2 pages, 489 KB)
By now you should have received information regarding the changes in access to atorvastatin being implemented from 1 June 2004. In essence these changes will result in patients that are on a dose below 40 mg of atorvastatin per day having their Special Authority cancelled.

text


page1

Special Authority approvals for atorvastatin (Lipitor) (40 pages, 828 KB)
Listing of active Special Authority approvals for atorvastatin (Lipitor) from 1 June 2004 (other than approvals under the new criteria).

text